Radiopharmaceuticals Market Outlook: Size, Share, Trends, Growth Analysis, Competitive Landscape & Forecast, 2026-2033

The Radiopharmaceuticals Market size was valued at US$ 12.43 Billion in 2025 and is projected to reach US$ 53.27 Billion by 2033, growing at a CAGR of 19.95% during 2026–2033, supported by cancer care advancements, precision medicine adoption, nuclear imaging expansion, isotope innovation, and healthcare infrastructure development.

Report Coverage

Type: Diagnostic, Therapeutic
Product Type: Technetium-99m, Fluorine-18, Iodine-131, Gallium-68, Lutetium-177, Yttrium-90, Actinium-225, Others
Application: Oncology, Cardiology, Neurology, Neuroendocrine Tumors, Bone Disorders, Renal Disorders, Others
End User: Hospitals, Diagnostic Imaging Centers, Nuclear Medicine Centers, Research Institutes, Pharmaceutical & Biotechnology Companies

US$ 12.43 Bn Market size in 2025

US$ 53.27 Bn Market Size by 2033

19.95% CAGR, 2026 - 2033

2026-2033 Forecast Period

Download Sample PDF Buy Now

Format PDF + Excel + PPT

No. of Pages: 350

Category Life Sciences

Report Code: BMIPUB00037003

Last Updated: 2026-08-31

Author

Krishna Sunthwal

Analyst Connect

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Radiopharmaceuticals Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Radiopharmaceuticals Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Radiopharmaceuticals Market Global Analysis

6.2 Radiopharmaceuticals Market Revenue 2022-2033 (US$ Billion)

6.3 Radiopharmaceuticals Market Forecast Analysis

7. Radiopharmaceuticals Market Analysis – by Type

7.1 Diagnostic

7.1.1 Overview
7.1.2 Diagnostic: Radiopharmaceuticals Market – Revenue and Forecast, 2022-2033 (US$ Billion)

7.2 Therapeutic

7.2.1 Overview
7.2.2 Therapeutic: Radiopharmaceuticals Market – Revenue and Forecast, 2022-2033 (US$ Billion)

8. Radiopharmaceuticals Market Analysis – by Product Type

8.1 Technetium-99m

8.1.1 Overview
8.1.2 Technetium-99m: Radiopharmaceuticals Market – Revenue and Forecast, 2022-2033 (US$ Billion)

8.2 Fluorine-18

8.2.1 Overview
8.2.2 Fluorine-18: Radiopharmaceuticals Market – Revenue and Forecast, 2022-2033 (US$ Billion)

8.3 Iodine-131

8.3.1 Overview
8.3.2 Iodine-131: Radiopharmaceuticals Market – Revenue and Forecast, 2022-2033 (US$ Billion)

8.4 Gallium-68

8.4.1 Overview
8.4.2 Gallium-68: Radiopharmaceuticals Market – Revenue and Forecast, 2022-2033 (US$ Billion)

8.5 Lutetium-177

8.5.1 Overview
8.5.2 Lutetium-177: Radiopharmaceuticals Market – Revenue and Forecast, 2022-2033 (US$ Billion)

8.6 Yttrium-90

8.6.1 Overview
8.6.2 Yttrium-90: Radiopharmaceuticals Market – Revenue and Forecast, 2022-2033 (US$ Billion)

8.7 Actinium-225

8.7.1 Overview
8.7.2 Actinium-225: Radiopharmaceuticals Market – Revenue and Forecast, 2022-2033 (US$ Billion)

8.8 Others

8.8.1 Overview
8.8.2 Others: Radiopharmaceuticals Market – Revenue and Forecast, 2022-2033 (US$ Billion)

9. Radiopharmaceuticals Market Analysis – by Application

9.1 Oncology

9.1.1 Overview
9.1.2 Oncology: Radiopharmaceuticals Market – Revenue and Forecast, 2022-2033 (US$ Billion)

9.2 Cardiology

9.2.1 Overview
9.2.2 Cardiology: Radiopharmaceuticals Market – Revenue and Forecast, 2022-2033 (US$ Billion)

9.3 Neurology

9.3.1 Overview
9.3.2 Neurology: Radiopharmaceuticals Market – Revenue and Forecast, 2022-2033 (US$ Billion)

9.4 Neuroendocrine Tumors

9.4.1 Overview
9.4.2 Neuroendocrine Tumors: Radiopharmaceuticals Market – Revenue and Forecast, 2022-2033 (US$ Billion)

9.5 Bone Disorders

9.5.1 Overview
9.5.2 Bone Disorders: Radiopharmaceuticals Market – Revenue and Forecast, 2022-2033 (US$ Billion)

9.6 Renal Disorders

9.6.1 Overview
9.6.2 Renal Disorders: Radiopharmaceuticals Market – Revenue and Forecast, 2022-2033 (US$ Billion)

9.7 Others

9.7.1 Overview
9.7.2 Others: Radiopharmaceuticals Market – Revenue and Forecast, 2022-2033 (US$ Billion)

10. Radiopharmaceuticals Market Analysis – by End User

10.1 Hospitals

10.1.1 Overview
10.1.2 Hospitals: Radiopharmaceuticals Market – Revenue and Forecast, 2022-2033 (US$ Billion)

10.2 Diagnostic Imaging Centers

10.2.1 Overview
10.2.2 Diagnostic Imaging Centers: Radiopharmaceuticals Market – Revenue and Forecast, 2022-2033 (US$ Billion)

10.3 Nuclear Medicine Centers

10.3.1 Overview
10.3.2 Nuclear Medicine Centers: Radiopharmaceuticals Market – Revenue and Forecast, 2022-2033 (US$ Billion)

10.4 Research Institutes

10.4.1 Overview
10.4.2 Research Institutes: Radiopharmaceuticals Market – Revenue and Forecast, 2022-2033 (US$ Billion)

10.5 Pharmaceutical & Biotechnology Companies

10.5.1 Overview
10.5.2 Pharmaceutical & Biotechnology Companies: Radiopharmaceuticals Market – Revenue and Forecast, 2022-2033 (US$ Billion)

11. Radiopharmaceuticals Market – Geographic Analysis

11.1 Overview

11.2 North America

11.2.1 Radiopharmaceuticals Market Breakdown, by Key Country, 2026 and 2033 (%)
11.2.1.1 Radiopharmaceuticals Market – Revenue and Forecast Analysis – by Country
11.2.1.1 US: Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

11.2.1.1.1 US: Radiopharmaceuticals Market Breakdown, by Type
11.2.1.1.2 US: Radiopharmaceuticals Market Breakdown, by Product Type
11.2.1.1.3 US: Radiopharmaceuticals Market Breakdown, by Application
11.2.1.1.4 US: Radiopharmaceuticals Market Breakdown, by End User

11.2.1.2 Canada: Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

11.2.1.2.1 Canada: Radiopharmaceuticals Market Breakdown, by Type
11.2.1.2.2 Canada: Radiopharmaceuticals Market Breakdown, by Product Type
11.2.1.2.3 Canada: Radiopharmaceuticals Market Breakdown, by Application
11.2.1.2.4 Canada: Radiopharmaceuticals Market Breakdown, by End User

11.2.1.3 Mexico : Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

11.2.1.3.1 Mexico : Radiopharmaceuticals Market Breakdown, by Type
11.2.1.3.2 Mexico : Radiopharmaceuticals Market Breakdown, by Product Type
11.2.1.3.3 Mexico : Radiopharmaceuticals Market Breakdown, by Application
11.2.1.3.4 Mexico : Radiopharmaceuticals Market Breakdown, by End User

11.3 Europe

11.3.1 Radiopharmaceuticals Market Breakdown, by Key Country, 2026 and 2033 (%)
11.3.1.1 Radiopharmaceuticals Market – Revenue and Forecast Analysis – by Country
11.3.1.1 Germany: Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.1.1 Germany: Radiopharmaceuticals Market Breakdown, by Type
11.3.1.1.2 Germany: Radiopharmaceuticals Market Breakdown, by Product Type
11.3.1.1.3 Germany: Radiopharmaceuticals Market Breakdown, by Application
11.3.1.1.4 Germany: Radiopharmaceuticals Market Breakdown, by End User

11.3.1.2 Italy: Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.2.1 Italy: Radiopharmaceuticals Market Breakdown, by Type
11.3.1.2.2 Italy: Radiopharmaceuticals Market Breakdown, by Product Type
11.3.1.2.3 Italy: Radiopharmaceuticals Market Breakdown, by Application
11.3.1.2.4 Italy: Radiopharmaceuticals Market Breakdown, by End User

11.3.1.3 France: Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.3.1 France: Radiopharmaceuticals Market Breakdown, by Type
11.3.1.3.2 France: Radiopharmaceuticals Market Breakdown, by Product Type
11.3.1.3.3 France: Radiopharmaceuticals Market Breakdown, by Application
11.3.1.3.4 France: Radiopharmaceuticals Market Breakdown, by End User

11.3.1.4 U.K.: Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.4.1 U.K.: Radiopharmaceuticals Market Breakdown, by Type
11.3.1.4.2 U.K.: Radiopharmaceuticals Market Breakdown, by Product Type
11.3.1.4.3 U.K.: Radiopharmaceuticals Market Breakdown, by Application
11.3.1.4.4 U.K.: Radiopharmaceuticals Market Breakdown, by End User

11.3.1.5 Spain: Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.5.1 Spain: Radiopharmaceuticals Market Breakdown, by Type
11.3.1.5.2 Spain: Radiopharmaceuticals Market Breakdown, by Product Type
11.3.1.5.3 Spain: Radiopharmaceuticals Market Breakdown, by Application
11.3.1.5.4 Spain: Radiopharmaceuticals Market Breakdown, by End User

11.3.1.6 Belgium: Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.6.1 Belgium: Radiopharmaceuticals Market Breakdown, by Type
11.3.1.6.2 Belgium: Radiopharmaceuticals Market Breakdown, by Product Type
11.3.1.6.3 Belgium: Radiopharmaceuticals Market Breakdown, by Application
11.3.1.6.4 Belgium: Radiopharmaceuticals Market Breakdown, by End User

11.3.1.7 Netherlands: Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.7.1 Netherlands: Radiopharmaceuticals Market Breakdown, by Type
11.3.1.7.2 Netherlands: Radiopharmaceuticals Market Breakdown, by Product Type
11.3.1.7.3 Netherlands: Radiopharmaceuticals Market Breakdown, by Application
11.3.1.7.4 Netherlands: Radiopharmaceuticals Market Breakdown, by End User

11.3.1.8 Luxembourg: Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.8.1 Luxembourg: Radiopharmaceuticals Market Breakdown, by Type
11.3.1.8.2 Luxembourg: Radiopharmaceuticals Market Breakdown, by Product Type
11.3.1.8.3 Luxembourg: Radiopharmaceuticals Market Breakdown, by Application
11.3.1.8.4 Luxembourg: Radiopharmaceuticals Market Breakdown, by End User

11.3.1.9 Norway: Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.9.1 Norway: Radiopharmaceuticals Market Breakdown, by Type
11.3.1.9.2 Norway: Radiopharmaceuticals Market Breakdown, by Product Type
11.3.1.9.3 Norway: Radiopharmaceuticals Market Breakdown, by Application
11.3.1.9.4 Norway: Radiopharmaceuticals Market Breakdown, by End User

11.3.1.10 Finland: Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.10.1 Finland: Radiopharmaceuticals Market Breakdown, by Type
11.3.1.10.2 Finland: Radiopharmaceuticals Market Breakdown, by Product Type
11.3.1.10.3 Finland: Radiopharmaceuticals Market Breakdown, by Application
11.3.1.10.4 Finland: Radiopharmaceuticals Market Breakdown, by End User

11.3.1.11 Denmark: Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.11.1 Denmark: Radiopharmaceuticals Market Breakdown, by Type
11.3.1.11.2 Denmark: Radiopharmaceuticals Market Breakdown, by Product Type
11.3.1.11.3 Denmark: Radiopharmaceuticals Market Breakdown, by Application
11.3.1.11.4 Denmark: Radiopharmaceuticals Market Breakdown, by End User

11.3.1.12 Sweden: Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.12.1 Sweden: Radiopharmaceuticals Market Breakdown, by Type
11.3.1.12.2 Sweden: Radiopharmaceuticals Market Breakdown, by Product Type
11.3.1.12.3 Sweden: Radiopharmaceuticals Market Breakdown, by Application
11.3.1.12.4 Sweden: Radiopharmaceuticals Market Breakdown, by End User

11.3.1.13 Switzerland: Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.13.1 Switzerland: Radiopharmaceuticals Market Breakdown, by Type
11.3.1.13.2 Switzerland: Radiopharmaceuticals Market Breakdown, by Product Type
11.3.1.13.3 Switzerland: Radiopharmaceuticals Market Breakdown, by Application
11.3.1.13.4 Switzerland: Radiopharmaceuticals Market Breakdown, by End User

11.3.1.14 Austria: Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.14.1 Austria: Radiopharmaceuticals Market Breakdown, by Type
11.3.1.14.2 Austria: Radiopharmaceuticals Market Breakdown, by Product Type
11.3.1.14.3 Austria: Radiopharmaceuticals Market Breakdown, by Application
11.3.1.14.4 Austria: Radiopharmaceuticals Market Breakdown, by End User

11.3.1.15 Greece: Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.15.1 Greece: Radiopharmaceuticals Market Breakdown, by Type
11.3.1.15.2 Greece: Radiopharmaceuticals Market Breakdown, by Product Type
11.3.1.15.3 Greece: Radiopharmaceuticals Market Breakdown, by Application
11.3.1.15.4 Greece: Radiopharmaceuticals Market Breakdown, by End User

11.3.1.16 Portugal: Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.16.1 Portugal: Radiopharmaceuticals Market Breakdown, by Type
11.3.1.16.2 Portugal: Radiopharmaceuticals Market Breakdown, by Product Type
11.3.1.16.3 Portugal: Radiopharmaceuticals Market Breakdown, by Application
11.3.1.16.4 Portugal: Radiopharmaceuticals Market Breakdown, by End User

11.3.1.17 Russia: Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.17.1 Russia: Radiopharmaceuticals Market Breakdown, by Type
11.3.1.17.2 Russia: Radiopharmaceuticals Market Breakdown, by Product Type
11.3.1.17.3 Russia: Radiopharmaceuticals Market Breakdown, by Application
11.3.1.17.4 Russia: Radiopharmaceuticals Market Breakdown, by End User

11.3.1.18 Poland: Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.18.1 Poland: Radiopharmaceuticals Market Breakdown, by Type
11.3.1.18.2 Poland: Radiopharmaceuticals Market Breakdown, by Product Type
11.3.1.18.3 Poland: Radiopharmaceuticals Market Breakdown, by Application
11.3.1.18.4 Poland: Radiopharmaceuticals Market Breakdown, by End User

11.3.1.19 Romania: Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.19.1 Romania: Radiopharmaceuticals Market Breakdown, by Type
11.3.1.19.2 Romania: Radiopharmaceuticals Market Breakdown, by Product Type
11.3.1.19.3 Romania: Radiopharmaceuticals Market Breakdown, by Application
11.3.1.19.4 Romania: Radiopharmaceuticals Market Breakdown, by End User

11.3.1.20 Czech Republic: Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.20.1 Czech Republic: Radiopharmaceuticals Market Breakdown, by Type
11.3.1.20.2 Czech Republic: Radiopharmaceuticals Market Breakdown, by Product Type
11.3.1.20.3 Czech Republic: Radiopharmaceuticals Market Breakdown, by Application
11.3.1.20.4 Czech Republic: Radiopharmaceuticals Market Breakdown, by End User

11.3.1.21 Ukraine: Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.21.1 Ukraine: Radiopharmaceuticals Market Breakdown, by Type
11.3.1.21.2 Ukraine: Radiopharmaceuticals Market Breakdown, by Product Type
11.3.1.21.3 Ukraine: Radiopharmaceuticals Market Breakdown, by Application
11.3.1.21.4 Ukraine: Radiopharmaceuticals Market Breakdown, by End User

11.3.1.22 Slovakia: Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.22.1 Slovakia: Radiopharmaceuticals Market Breakdown, by Type
11.3.1.22.2 Slovakia: Radiopharmaceuticals Market Breakdown, by Product Type
11.3.1.22.3 Slovakia: Radiopharmaceuticals Market Breakdown, by Application
11.3.1.22.4 Slovakia: Radiopharmaceuticals Market Breakdown, by End User

11.3.1.23 Bulgaria : Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

11.3.1.23.1 Bulgaria : Radiopharmaceuticals Market Breakdown, by Type
11.3.1.23.2 Bulgaria : Radiopharmaceuticals Market Breakdown, by Product Type
11.3.1.23.3 Bulgaria : Radiopharmaceuticals Market Breakdown, by Application
11.3.1.23.4 Bulgaria : Radiopharmaceuticals Market Breakdown, by End User

11.4 Asia-Pacific

11.4.1 Radiopharmaceuticals Market Breakdown, by Key Country, 2026 and 2033 (%)
11.4.1.1 Radiopharmaceuticals Market – Revenue and Forecast Analysis – by Country
11.4.1.1 China: Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

11.4.1.1.1 China: Radiopharmaceuticals Market Breakdown, by Type
11.4.1.1.2 China: Radiopharmaceuticals Market Breakdown, by Product Type
11.4.1.1.3 China: Radiopharmaceuticals Market Breakdown, by Application
11.4.1.1.4 China: Radiopharmaceuticals Market Breakdown, by End User

11.4.1.2 Japan: Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

11.4.1.2.1 Japan: Radiopharmaceuticals Market Breakdown, by Type
11.4.1.2.2 Japan: Radiopharmaceuticals Market Breakdown, by Product Type
11.4.1.2.3 Japan: Radiopharmaceuticals Market Breakdown, by Application
11.4.1.2.4 Japan: Radiopharmaceuticals Market Breakdown, by End User

11.4.1.3 South Korea: Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

11.4.1.3.1 South Korea: Radiopharmaceuticals Market Breakdown, by Type
11.4.1.3.2 South Korea: Radiopharmaceuticals Market Breakdown, by Product Type
11.4.1.3.3 South Korea: Radiopharmaceuticals Market Breakdown, by Application
11.4.1.3.4 South Korea: Radiopharmaceuticals Market Breakdown, by End User

11.4.1.4 India: Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

11.4.1.4.1 India: Radiopharmaceuticals Market Breakdown, by Type
11.4.1.4.2 India: Radiopharmaceuticals Market Breakdown, by Product Type
11.4.1.4.3 India: Radiopharmaceuticals Market Breakdown, by Application
11.4.1.4.4 India: Radiopharmaceuticals Market Breakdown, by End User

11.4.1.5 Australia: Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

11.4.1.5.1 Australia: Radiopharmaceuticals Market Breakdown, by Type
11.4.1.5.2 Australia: Radiopharmaceuticals Market Breakdown, by Product Type
11.4.1.5.3 Australia: Radiopharmaceuticals Market Breakdown, by Application
11.4.1.5.4 Australia: Radiopharmaceuticals Market Breakdown, by End User

11.4.1.6 New Zealand: Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

11.4.1.6.1 New Zealand: Radiopharmaceuticals Market Breakdown, by Type
11.4.1.6.2 New Zealand: Radiopharmaceuticals Market Breakdown, by Product Type
11.4.1.6.3 New Zealand: Radiopharmaceuticals Market Breakdown, by Application
11.4.1.6.4 New Zealand: Radiopharmaceuticals Market Breakdown, by End User

11.4.1.7 Indonesia: Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

11.4.1.7.1 Indonesia: Radiopharmaceuticals Market Breakdown, by Type
11.4.1.7.2 Indonesia: Radiopharmaceuticals Market Breakdown, by Product Type
11.4.1.7.3 Indonesia: Radiopharmaceuticals Market Breakdown, by Application
11.4.1.7.4 Indonesia: Radiopharmaceuticals Market Breakdown, by End User

11.4.1.8 Malaysia: Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

11.4.1.8.1 Malaysia: Radiopharmaceuticals Market Breakdown, by Type
11.4.1.8.2 Malaysia: Radiopharmaceuticals Market Breakdown, by Product Type
11.4.1.8.3 Malaysia: Radiopharmaceuticals Market Breakdown, by Application
11.4.1.8.4 Malaysia: Radiopharmaceuticals Market Breakdown, by End User

11.4.1.9 Philippines: Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

11.4.1.9.1 Philippines: Radiopharmaceuticals Market Breakdown, by Type
11.4.1.9.2 Philippines: Radiopharmaceuticals Market Breakdown, by Product Type
11.4.1.9.3 Philippines: Radiopharmaceuticals Market Breakdown, by Application
11.4.1.9.4 Philippines: Radiopharmaceuticals Market Breakdown, by End User

11.4.1.10 Singapore: Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

11.4.1.10.1 Singapore: Radiopharmaceuticals Market Breakdown, by Type
11.4.1.10.2 Singapore: Radiopharmaceuticals Market Breakdown, by Product Type
11.4.1.10.3 Singapore: Radiopharmaceuticals Market Breakdown, by Application
11.4.1.10.4 Singapore: Radiopharmaceuticals Market Breakdown, by End User

11.4.1.11 Thailand: Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

11.4.1.11.1 Thailand: Radiopharmaceuticals Market Breakdown, by Type
11.4.1.11.2 Thailand: Radiopharmaceuticals Market Breakdown, by Product Type
11.4.1.11.3 Thailand: Radiopharmaceuticals Market Breakdown, by Application
11.4.1.11.4 Thailand: Radiopharmaceuticals Market Breakdown, by End User

11.4.1.12 Vietnam: Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

11.4.1.12.1 Vietnam: Radiopharmaceuticals Market Breakdown, by Type
11.4.1.12.2 Vietnam: Radiopharmaceuticals Market Breakdown, by Product Type
11.4.1.12.3 Vietnam: Radiopharmaceuticals Market Breakdown, by Application
11.4.1.12.4 Vietnam: Radiopharmaceuticals Market Breakdown, by End User

11.4.1.13 Taiwan: Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

11.4.1.13.1 Taiwan: Radiopharmaceuticals Market Breakdown, by Type
11.4.1.13.2 Taiwan: Radiopharmaceuticals Market Breakdown, by Product Type
11.4.1.13.3 Taiwan: Radiopharmaceuticals Market Breakdown, by Application
11.4.1.13.4 Taiwan: Radiopharmaceuticals Market Breakdown, by End User

11.4.1.14 Bangladesh : Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

11.4.1.14.1 Bangladesh : Radiopharmaceuticals Market Breakdown, by Type
11.4.1.14.2 Bangladesh : Radiopharmaceuticals Market Breakdown, by Product Type
11.4.1.14.3 Bangladesh : Radiopharmaceuticals Market Breakdown, by Application
11.4.1.14.4 Bangladesh : Radiopharmaceuticals Market Breakdown, by End User

11.5 South and Central America

11.5.1 Radiopharmaceuticals Market Breakdown, by Key Country, 2026 and 2033 (%)
11.5.1.1 Radiopharmaceuticals Market – Revenue and Forecast Analysis – by Country
11.5.1.1 Brazil: Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

11.5.1.1.1 Brazil: Radiopharmaceuticals Market Breakdown, by Type
11.5.1.1.2 Brazil: Radiopharmaceuticals Market Breakdown, by Product Type
11.5.1.1.3 Brazil: Radiopharmaceuticals Market Breakdown, by Application
11.5.1.1.4 Brazil: Radiopharmaceuticals Market Breakdown, by End User

11.5.1.2 Argentina: Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

11.5.1.2.1 Argentina: Radiopharmaceuticals Market Breakdown, by Type
11.5.1.2.2 Argentina: Radiopharmaceuticals Market Breakdown, by Product Type
11.5.1.2.3 Argentina: Radiopharmaceuticals Market Breakdown, by Application
11.5.1.2.4 Argentina: Radiopharmaceuticals Market Breakdown, by End User

11.5.1.3 Chile: Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

11.5.1.3.1 Chile: Radiopharmaceuticals Market Breakdown, by Type
11.5.1.3.2 Chile: Radiopharmaceuticals Market Breakdown, by Product Type
11.5.1.3.3 Chile: Radiopharmaceuticals Market Breakdown, by Application
11.5.1.3.4 Chile: Radiopharmaceuticals Market Breakdown, by End User

11.5.1.4 Colombia: Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

11.5.1.4.1 Colombia: Radiopharmaceuticals Market Breakdown, by Type
11.5.1.4.2 Colombia: Radiopharmaceuticals Market Breakdown, by Product Type
11.5.1.4.3 Colombia: Radiopharmaceuticals Market Breakdown, by Application
11.5.1.4.4 Colombia: Radiopharmaceuticals Market Breakdown, by End User

11.5.1.5 Peru : Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

11.5.1.5.1 Peru : Radiopharmaceuticals Market Breakdown, by Type
11.5.1.5.2 Peru : Radiopharmaceuticals Market Breakdown, by Product Type
11.5.1.5.3 Peru : Radiopharmaceuticals Market Breakdown, by Application
11.5.1.5.4 Peru : Radiopharmaceuticals Market Breakdown, by End User

11.6 Middle East and Africa

11.6.1 Radiopharmaceuticals Market Breakdown, by Key Country, 2026 and 2033 (%)
11.6.1.1 Radiopharmaceuticals Market – Revenue and Forecast Analysis – by Country
11.6.1.1 Saudi Arabia: Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

11.6.1.1.1 Saudi Arabia: Radiopharmaceuticals Market Breakdown, by Type
11.6.1.1.2 Saudi Arabia: Radiopharmaceuticals Market Breakdown, by Product Type
11.6.1.1.3 Saudi Arabia: Radiopharmaceuticals Market Breakdown, by Application
11.6.1.1.4 Saudi Arabia: Radiopharmaceuticals Market Breakdown, by End User

11.6.1.2 United Arab Emirates: Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

11.6.1.2.1 United Arab Emirates: Radiopharmaceuticals Market Breakdown, by Type
11.6.1.2.2 United Arab Emirates: Radiopharmaceuticals Market Breakdown, by Product Type
11.6.1.2.3 United Arab Emirates: Radiopharmaceuticals Market Breakdown, by Application
11.6.1.2.4 United Arab Emirates: Radiopharmaceuticals Market Breakdown, by End User

11.6.1.3 Kuwait: Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

11.6.1.3.1 Kuwait: Radiopharmaceuticals Market Breakdown, by Type
11.6.1.3.2 Kuwait: Radiopharmaceuticals Market Breakdown, by Product Type
11.6.1.3.3 Kuwait: Radiopharmaceuticals Market Breakdown, by Application
11.6.1.3.4 Kuwait: Radiopharmaceuticals Market Breakdown, by End User

11.6.1.4 Bahrain: Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

11.6.1.4.1 Bahrain: Radiopharmaceuticals Market Breakdown, by Type
11.6.1.4.2 Bahrain: Radiopharmaceuticals Market Breakdown, by Product Type
11.6.1.4.3 Bahrain: Radiopharmaceuticals Market Breakdown, by Application
11.6.1.4.4 Bahrain: Radiopharmaceuticals Market Breakdown, by End User

11.6.1.5 Qatar: Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

11.6.1.5.1 Qatar: Radiopharmaceuticals Market Breakdown, by Type
11.6.1.5.2 Qatar: Radiopharmaceuticals Market Breakdown, by Product Type
11.6.1.5.3 Qatar: Radiopharmaceuticals Market Breakdown, by Application
11.6.1.5.4 Qatar: Radiopharmaceuticals Market Breakdown, by End User

11.6.1.6 Oman: Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

11.6.1.6.1 Oman: Radiopharmaceuticals Market Breakdown, by Type
11.6.1.6.2 Oman: Radiopharmaceuticals Market Breakdown, by Product Type
11.6.1.6.3 Oman: Radiopharmaceuticals Market Breakdown, by Application
11.6.1.6.4 Oman: Radiopharmaceuticals Market Breakdown, by End User

11.6.1.7 Turkiye: Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

11.6.1.7.1 Turkiye: Radiopharmaceuticals Market Breakdown, by Type
11.6.1.7.2 Turkiye: Radiopharmaceuticals Market Breakdown, by Product Type
11.6.1.7.3 Turkiye: Radiopharmaceuticals Market Breakdown, by Application
11.6.1.7.4 Turkiye: Radiopharmaceuticals Market Breakdown, by End User

11.6.1.8 South Africa: Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

11.6.1.8.1 South Africa: Radiopharmaceuticals Market Breakdown, by Type
11.6.1.8.2 South Africa: Radiopharmaceuticals Market Breakdown, by Product Type
11.6.1.8.3 South Africa: Radiopharmaceuticals Market Breakdown, by Application
11.6.1.8.4 South Africa: Radiopharmaceuticals Market Breakdown, by End User

11.6.1.9 Egypt: Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

11.6.1.9.1 Egypt: Radiopharmaceuticals Market Breakdown, by Type
11.6.1.9.2 Egypt: Radiopharmaceuticals Market Breakdown, by Product Type
11.6.1.9.3 Egypt: Radiopharmaceuticals Market Breakdown, by Application
11.6.1.9.4 Egypt: Radiopharmaceuticals Market Breakdown, by End User

11.6.1.10 Nigeria: Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

11.6.1.10.1 Nigeria: Radiopharmaceuticals Market Breakdown, by Type
11.6.1.10.2 Nigeria: Radiopharmaceuticals Market Breakdown, by Product Type
11.6.1.10.3 Nigeria: Radiopharmaceuticals Market Breakdown, by Application
11.6.1.10.4 Nigeria: Radiopharmaceuticals Market Breakdown, by End User

11.6.1.11 Algeria: Radiopharmaceuticals Market – Revenue and Forecast to 2033 (US$ Billion)

11.6.1.11.1 Algeria: Radiopharmaceuticals Market Breakdown, by Type
11.6.1.11.2 Algeria: Radiopharmaceuticals Market Breakdown, by Product Type
11.6.1.11.3 Algeria: Radiopharmaceuticals Market Breakdown, by Application
11.6.1.11.4 Algeria: Radiopharmaceuticals Market Breakdown, by End User

12. Competitive Landscape

12.1 Heat Map Analysis

12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview

13.2 Market Initiative

13.3 Partnerships and Collaborations

13.4 Other Developments

14. Company Profiles

14.1 Curium Pharma

14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments

14.2 GE HealthCare

14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments

14.3 Cardinal Health, Inc.

14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments

14.4 Lantheus Holdings, Inc.

14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments

14.5 Novartis AG

14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments

14.6 Bracco Imaging S.p.A.

14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments

14.7 Bayer AG

14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments

14.8 Eckert & Ziegler SE

14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments

14.9 Jubilant Radiopharma

14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments

14.10 Telix Pharmaceuticals Limited

14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments

15. Appendix

15.1 About Business Market Insights

15.2 List of Abbreviations

Access the Full R Market Report

Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.

Download Sample Request Customization